- List
- By Topic
- On Map
- Search Details

"Abdominal obesity metabolic syndrome"
Need help? See RSS Feeds
Choose a feed type:

"Abdominal obesity metabolic syndrome" (1083 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT03020186 | Recruiting | Effects of Green-MED Diet Via the Gut-fat-brain Axis |
|
|
Interventional | Not Applicable |
|
Other |
|
|
270 | All | 30 Years and older (Adult, Senior) | NCT03020186 | BGU | DIRECT-PLUS | November 2016 | October 2018 | October 2020 | January 13, 2017 | January 13, 2017 |
|
|
2 | NCT02954588 | Recruiting | Effect of Pyridoxamine Supplementation on Vascular Function and Insulin Sensitivity |
|
|
Interventional | Not Applicable |
|
Other |
|
|
120 | All | 18 Years to 65 Years (Adult) | NCT02954588 | NL51023.068.16 | October 2016 | October 2018 | November 3, 2016 | November 3, 2016 |
|
|||
3 | NCT02283242 | Completed | Galantamine Effects in Patients With Metabolic Syndrome |
|
|
Interventional | Phase 4 |
|
Other |
|
|
60 | All | 18 Years to 59 Years (Adult) | NCT02283242 | CAAE:27386114.9.0000.0068 2013/22250-9 |
GALANTA-MS | March 2014 | March 2015 | February 2017 | November 5, 2014 | February 15, 2017 |
|
|
4 | NCT01872182 | Terminated | Efficacy and Safety Study of ALS-L1023 in Patients With Abdominal Obesity of Metabolic Syndrome |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
200 | All | 20 Years to 64 Years (Adult) | NCT01872182 | HM-MELS-301 | May 2013 | January 2015 | January 2015 | June 7, 2013 | October 11, 2016 |
|
||
5 | NCT02626741 | Unknown † | Effect of a Meal Replacement on Weight Loss Obesity Patients With Metabolic Syndrome |
|
|
Interventional | Phase 3 |
|
Other |
|
|
138 | All | 18 Years and older (Adult, Senior) | NCT02626741 | 647-2557-EC4 | SlimWell | February 2015 | February 2016 | April 2016 | December 10, 2015 | December 10, 2015 |
|
|
6 | NCT02480673 | Unknown † | EFFECT OF Salvia Hispanica l. (CHIA) IN THE BIOCHEMICAL METABOLIC SYNDROME COMPONENTS |
|
|
Interventional | Not Applicable |
|
Other |
|
|
100 | All | 18 Years to 50 Years (Adult) | NCT02480673 | R-2015-785-047 | June 2015 | December 2015 | May 2016 | June 24, 2015 | June 26, 2015 |
|
||
7 | NCT01577277 | Completed | OPUS School Meal Study - Cross Sectional Analyses From Baseline Investigations |
|
Observational |
|
Other |
|
|
834 | All | 8 Years to 12 Years (Child) | NCT01577277 | D208 baseline H-1-2010-124 |
May 2011 | December 2011 | December 2011 | April 13, 2012 | March 6, 2017 |
|
||||
8 | NCT01457794 | Completed | OPUS School Meal Study |
|
|
Interventional | Not Applicable |
|
Other |
|
|
834 | All | 8 Years to 11 Years (Child) | NCT01457794 | D208 H-1-2010-124 |
May 2011 | June 2012 | June 2012 | October 24, 2011 | March 6, 2017 |
|
||
9 | NCT02356952 | Completed | Effect of a Low Glycemic Index on Metabolic Syndrome |
|
|
Interventional | Not Applicable |
|
Other |
|
|
163 | All | 30 Years to 89 Years (Adult, Senior) | NCT02356952 | Medidiet | September 2014 | June 2015 | August 2015 | February 6, 2015 | July 26, 2016 |
|
||
10 | NCT03310359 | Recruiting | Clinical Trial of Anti-oxidant Astaxanthin in Insulin-resistant Subjects |
|
|
Interventional | Phase 1 |
|
Other |
|
|
34 | All | 18 Years to 75 Years (Adult, Senior) | NCT03310359 | 151542 | Astaxanthin | July 2016 | April 2018 | April 2018 | October 16, 2017 | October 16, 2017 |
|
|
11 | NCT02495961 | Completed | Study of Chronic Degenerative Diseases |
|
Observational |
|
Other |
|
|
57 | All | 6 Years to 12 Years (Child) | NCT02495961 | 2014-01 | June 2015 | January 2016 | February 2016 | July 13, 2015 | February 17, 2016 |
|
||||
12 | NCT02042274 | Completed Has Results |
Efficacy Study Regarding the Beneficial Effects of Omega-3 Fatty Acids on Cardiometabolic Health |
|
|
Interventional | Not Applicable |
|
Other |
|
|
12 | Male | 18 Years to 30 Years (Adult) | NCT02042274 | Fish Oil and Health Study 12JL006 |
FOHS | October 2012 | March 2013 | February 2015 | January 22, 2014 | April 5, 2017 | April 5, 2017 |
|
13 | NCT02288572 | Completed | Probiotic Bacteria in Prevention of the Metabolic Syndrome |
|
|
Interventional | Phase 2 |
|
Other |
|
|
16 | All | 21 Years to 85 Years (Adult, Senior) | NCT02288572 | MGPS001 | May 2013 | March 2014 | May 2014 | November 11, 2014 | November 11, 2014 | |||
14 | NCT00956189 | Completed | Identification and Treatment Response Prediction of Antipsychotic-Related Metabolic Syndrome |
|
|
Interventional | Not Applicable |
|
Other |
|
|
132 | All | 20 Years and older (Adult, Senior) | NCT00956189 | 200812110M | November 2009 | August 2012 | October 2012 | August 11, 2009 | January 3, 2013 |
|
||
15 | NCT01548300 | Completed | Environmental Triggers Of Cardiometabolic Disease |
|
Observational |
|
Other / NIH |
|
|
66 | All | 35 Years to 65 Years (Adult) | NCT01548300 | HP-00059994 R01ES019616 |
AIRCMD | February 2011 | December 2014 | December 2014 | March 8, 2012 | February 8, 2018 |
|
|||
16 | NCT01173380 | Completed | Soy Nut Study on Markers of Health |
|
|
Interventional | Not Applicable |
|
Other |
|
|
18 | All | 21 Years and older (Adult, Senior) | NCT01173380 | 200715715-4 | August 2010 | September 2012 | September 2012 | August 2, 2010 | May 30, 2017 |
|
||
17 | NCT02001376 | Unknown † | A Health Promotion Project for Workers at National Taiwan University Hospital |
|
|
Interventional | Not Applicable |
|
Other |
|
|
240 | All | 20 Years to 60 Years (Adult) | NCT02001376 | 201007040R | April 2011 | December 2014 | December 2014 | December 4, 2013 | December 4, 2013 |
|
||
18 | NCT00695825 | Unknown † | Effects the Glycemic Index on Metabolic Risk Markers |
|
|
Interventional | Not Applicable |
|
Other |
|
|
30 | Male | 18 Years to 65 Years (Adult) | NCT00695825 | 073101 | February 2008 | November 2008 | December 2008 | June 12, 2008 | December 12, 2008 |
|
||
19 | NCT00561626 | Completed | Effects of High-fat and Low-fat Diet on the Gut |
|
|
Interventional | Not Applicable |
|
Other |
|
|
10 | Male | 18 Years to 65 Years (Adult) | NCT00561626 | 07-3-088 | January 2008 | October 2008 | December 2008 | November 21, 2007 | February 24, 2017 |
|
||
20 | NCT00558740 | Completed | Effects of Dietary Proteins on Hepatic Lipid Metabolism |
|
|
Observational |
|
Other |
|
|
22 | Male | 18 Years to 30 Years (Adult) | NCT00558740 | protocol 66/07/CE/FBM SNF 310000-109737 |
January 2009 | April 2009 | April 2009 | November 15, 2007 | February 10, 2012 |
|
|||
21 | NCT00515021 | Unknown † | Diurnal Variation of Plasminogen Activator Inhibitor-1 |
|
|
Interventional | Phase 4 |
|
Other / NIH |
|
|
40 | All | 18 Years to 65 Years (Adult) | NCT00515021 | 070183 | April 2007 | April 2010 | April 2010 | August 13, 2007 | January 29, 2009 |
|
||
22 | NCT00147264 | Completed | Telmisartan-Induced Reduction in Intra-Myocellular Lipids Trial |
|
|
Interventional | Phase 3 |
|
Other / Industry |
|
|
120 | All | 30 Years to 70 Years (Adult, Senior) | NCT00147264 | 502.433 BI Pharmaceuticals - 502.433 CIHR - 116099 |
April 2004 | January 2006 | November 2006 | September 7, 2005 | December 14, 2016 |
|
||
23 | NCT02969720 | Not yet recruiting | Therapeutic Efficacy of Phytosterols on Metabolic Syndrome |
|
|
Interventional | Phase 3 |
|
Other |
|
|
200 | All | 18 Years to 65 Years (Adult) | NCT02969720 | FESIME-016 | FESIME | March 2017 | October 2017 | December 2017 | November 21, 2016 | November 21, 2016 | ||
24 | NCT02958579 | Recruiting | a Population Based Study on Metabolic Syndrome Complications, and Mortality |
|
|
Observational |
|
Other |
|
|
10000 | All | 40 Years to 70 Years (Adult, Senior) | NCT02958579 | 95-03-191-33053 957275 |
MetSCoM | January 2005 | January 2017 | January 2020 | November 8, 2016 | November 8, 2016 |
|
||
25 | NCT02949622 | Completed | Multimodal Intervention Program for Patients With Metabolic Syndrome |
|
|
Interventional | Not Applicable |
|
Other |
|
|
136 | All | 25 Years to 65 Years (Adult) | NCT02949622 | CAPES 5566-10-0 | PROMETS | February 2013 | September 2016 | October 2016 | October 31, 2016 | June 21, 2017 |
|
|
26 | NCT02936687 | Recruiting | Mechanisms of Cerebrovascular Control |
|
|
Interventional | Phase 1 |
|
Other |
|
|
60 | All | 18 Years to 45 Years (Adult) | NCT02936687 | 2015-0197 | January 31, 2017 | December 2018 | December 2018 | October 18, 2016 | August 18, 2017 |
|
||
27 | NCT02918422 | Active, not recruiting | Controlled Clinical Study to Determine Novel Health Benefits of Cheese Consumption |
|
|
Interventional | Not Applicable |
|
Other |
|
|
30 | All | 21 Years to 65 Years (Adult) | NCT02918422 | GRT00036921 60047084 |
September 2015 | April 2018 | September 2018 | September 29, 2016 | April 5, 2018 |
|
||
28 | NCT02783703 | Recruiting | Evaluation of MCT in a Mixed Racial Population of Patients With Metabolic Syndrome: a Feasibility Study |
|
|
Interventional | Not Applicable |
|
Other |
|
|
20 | All | 18 Years to 65 Years (Adult) | NCT02783703 | H-35267 | April 28, 2017 | June 2018 | June 2018 | May 26, 2016 | January 4, 2018 |
|
||
29 | NCT02479113 | Recruiting | Maternal Hypertriglyceridaemia Study |
|
|
Observational |
|
Other |
|
|
400 | Female | 18 Years and older (Adult, Senior) | NCT02479113 | 201401-0691 | March 2014 | December 2018 | December 2024 | June 24, 2015 | November 1, 2016 |
|
|||
30 | NCT02696304 | Unknown † | The Metabolic Syndrome Among Leukemia Survivors: Physiopathological Analysis |
|
|
Interventional | Not Applicable |
|
Other |
|
|
30 | All | 18 Years and older (Adult, Senior) | NCT02696304 | 2015-A00170-49 2015-05 |
LEAMS | May 2015 | May 2016 | December 2016 | March 2, 2016 | March 2, 2016 |
|
|
31 | NCT02606812 | Not yet recruiting | Effect of Food Consumption on microRNA Related to Metabolic Syndrome |
|
|
Interventional | Not Applicable |
|
Other |
|
|
50 | All | 20 Years to 22 Years (Adult) | NCT02606812 | UniversidadJAT | EFCMRNAMS | March 2017 | April 2017 | April 2018 | November 17, 2015 | October 26, 2016 | ||
32 | NCT02605655 | Completed | Clinical Trial of Chinese Formula AMP-1915 on Metabolic Syndrome |
|
|
Interventional | Early Phase 1 |
|
Other |
|
|
60 | All | 40 Years to 65 Years (Adult) | NCT02605655 | ShanghaiUTCM-01 | June 2014 | December 2014 | April 2015 | November 16, 2015 | January 7, 2016 | |||
33 | NCT02542176 | Completed | Effects of a Standardized Freeze-dried Grape Powder on High Density Lipoprotein (HDL) Function in Metabolic Syndrome |
|
|
Interventional | Not Applicable |
|
Other |
|
|
20 | All | 30 Years to 70 Years (Adult, Senior) | NCT02542176 | 150888 | October 2015 | March 2018 | March 2018 | September 4, 2015 | March 23, 2018 |
|
||
34 | NCT02531334 | Active, not recruiting | Effects of TA-65, a Telomerase Activator on Metabolic Syndrome |
|
|
Interventional | Not Applicable |
|
Other |
|
|
40 | All | 32 Years to 70 Years (Adult, Senior) | NCT02531334 | H14-278 | August 2015 | December 2017 | June 2018 | August 24, 2015 | February 8, 2018 |
|
||
35 | NCT02407522 | Completed | The Improvements of Dietary Supplement of Black Rice on Metabolic Syndrome |
|
|
Interventional | Phase 2 Phase 3 |
|
Other |
|
|
101 | All | 40 Years to 80 Years (Adult, Senior) | NCT02407522 | SunYat-senU001 | IDSBRMS | June 2014 | December 2014 | December 2014 | April 3, 2015 | April 3, 2015 | ||
36 | NCT01849068 | Completed Has Results |
Effects of Selective Inhibition of Cholesterol Absorption With Ezetimibe on Intestinal Cholesterol Homeostasis in Dyslipidemic Men With Insulin-resistance - a Pilot Study |
|
|
Interventional | Phase 3 |
|
Other |
|
|
20 | Male | 18 Years to 60 Years (Adult) | NCT01849068 | INAF-B13-04-1195 | EZEmRNA | June 2013 | June 2015 | February 2016 | May 8, 2013 | April 12, 2016 | April 12, 2016 |
|
37 | NCT01944124 | Completed | Exercise and Technology to Reduce Risk in a Rural Population With Metabolic Syndrome |
|
|
Interventional | Not Applicable |
|
Other |
|
|
149 | All | 18 Years to 70 Years (Adult, Senior) | NCT01944124 | 15828 | November 2009 | March 2011 | December 2011 | September 17, 2013 | October 22, 2013 |
|
||
38 | NCT01829945 | Completed | Study of the Relationships Between Apolipoprotein B-48 Kinetics and Expression of Genes That Regulate Intestinal Lipid Metabolism in Men With the Metabolic Syndrome (SMB48) |
|
Observational |
|
Other |
|
|
30 | Male | 18 Years to 60 Years (Adult) | NCT01829945 | INAF-129-05-02 | October 2009 | February 2010 | February 2011 | April 11, 2013 | April 11, 2013 |
|
||||
39 | NCT01694056 | Completed | Soy Protein Intake and the Metabolic Syndrome |
|
|
Interventional | Not Applicable |
|
Other |
|
|
15 | Female | 45 Years to 70 Years (Adult, Senior) | NCT01694056 | NL39991.081.12 | SOY | September 2012 | December 2012 | December 2012 | September 26, 2012 | January 4, 2013 |
|
|
40 | NCT01022411 | Completed | Brown Rice Intervention on Metabolic Syndrome (BRIMS) |
|
|
Interventional | Phase 2 Phase 3 |
|
Other |
|
|
202 | All | 35 Years to 60 Years (Adult) | NCT01022411 | KSCX1-YW-02-BR | BRIMS | October 2009 | July 2010 | October 2010 | December 1, 2009 | October 21, 2010 |
|
|
41 | NCT00742742 | Completed | Walnut Intervention on Metabolic Syndrome (WIMS) |
|
|
Interventional | Phase 2 Phase 3 |
|
Other |
|
|
189 | All | 35 Years to 60 Years (Adult) | NCT00742742 | CWC-2008 KSCX1-YW-02 |
WIMS | March 2009 | July 2009 | December 2009 | August 28, 2008 | February 5, 2015 |
|
|
42 | NCT00733772 | Completed | Flaxseed Intervention on Metabolic Syndrome |
|
|
Interventional | Phase 2 Phase 3 |
|
Other |
|
|
189 | All | 35 Years to 60 Years (Adult) | NCT00733772 | KSCX1-YW-02 | FIMS | March 2009 | July 2009 | December 2009 | August 13, 2008 | February 5, 2015 |
|
|
43 | NCT00716300 | Unknown † | High Density Lipoprotein (HDL) Functionality in Metabolic Syndrome |
|
Observational |
|
Other |
|
30 | All | 20 Years to 75 Years (Adult, Senior) | NCT00716300 | DC-HDL2008 | July 2008 | June 2009 | December 2009 | July 16, 2008 | February 18, 2009 |
|
|||||
44 | NCT00608465 | Terminated Has Results |
Defining Strategies for Improving Endothelial and Fibrinolytic Dysfunction in Obesity |
|
|
Interventional | Phase 4 |
|
Other |
|
|
4 | All | 18 Years and older (Adult, Senior) | NCT00608465 | 060369 | May 2006 | May 2009 | May 2011 | February 6, 2008 | August 11, 2017 | May 1, 2017 |
|
|
45 | NCT00400231 | Completed | The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
124 | All | 18 Years to 75 Years (Adult, Senior) | NCT00400231 | 800860 | August 2005 | December 2007 | March 2008 | November 16, 2006 | March 20, 2017 |
|
||
46 | NCT00515476 | Completed | Effect of Exercise Training on the Function of the High Density Lipoprotein (HDL)-Cholesterol, Endothelial Function and Endothelial Progenitor Cells in Patients With Metabolic Syndrome(HERMET-Study) |
|
|
Interventional | Not Applicable |
|
Other |
|
|
24 | All | 21 Years to 75 Years (Adult, Senior) | NCT00515476 | 4031215 | HERMET | June 2007 | November 2008 | December 2008 | August 13, 2007 | June 23, 2010 |
|
|
47 | NCT00489333 | Completed | ProAlgaZyme Novel Algae Infusion: Applications in Metabolic Syndrome |
|
|
Interventional | Not Applicable |
|
Industry / Other |
|
|
52 | All | 25 Years to 60 Years (Adult) | NCT00489333 | H-0001-01 087/2006 |
May 2006 | September 2006 | June 21, 2007 | June 21, 2007 |
|
|||
48 | NCT00395486 | Completed Has Results |
ROMEO (Rosuvastatin in Metabolic syndrOme) |
|
|
Interventional | Phase 4 |
|
Industry |
|
|
258 | All | 18 Years and older (Adult, Senior) | NCT00395486 | D3560L00061 ROMEO |
September 2006 | June 2008 | June 2008 | November 3, 2006 | July 11, 2011 | June 16, 2011 |
|
|
49 | NCT00264667 | Completed | Study In Patients With Dyslipidaemia |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
290 | All | 18 Years to 70 Years (Adult, Senior) | NCT00264667 | ADG103440 | December 2005 | June 2007 | December 13, 2005 | October 28, 2016 |
|
|||
50 | NCT00350194 | Unknown † | The Effects of Omega-3 Fatty Acids on Metabolic Syndrome |
|
|
Interventional | Early Phase 1 |
|
Other / Industry / NIH |
|
|
100 | All | 18 Years to 75 Years (Adult, Senior) | NCT00350194 | 28791-D 05-8693-D 03 |
October 2006 | October 2011 | June 2012 | July 10, 2006 | March 2, 2012 |
|
† Study has passed its completion date and status has not been verified in more than two years.